Zhen Zeng Australasian Melanoma Conference 2026

Zhen Zeng

Abstracts this author is presenting:

• Checkpoint kinase 1 inhibitor + low-dose hydroxyurea overcomes therapeutic resistance in melanoma and is enhanced by targeting tumour-associated macrophages — Poster Session 1